Carboni L., Proteomics of Preclinical Models of Depression, in: Proteomics and Metabolomics in Psychiatry, Basel, KARGER, 2014, pp. 92 - 102 [capitolo di libro]
Malki K.; Keers R.; Tosto M.G.; Lourdusamy A.; Carboni L.; Domenici E.; Uher R.; McGuffin P.; Schalkwyk L.C., The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder., «BMC MEDICINE», 2014, 12, pp. 73 - 86 [articolo]
Laura Caberlotto; Lucia Carboni; Floriana Zanderigo; Filippo Andreetta; Michela Andreoli; Gabriella Gentile; Maria Razzoli, Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system, «NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY», 2013, 386, pp. 893 - 903 [articolo]
Lucia Carboni, Peripheral biomarkers in animal models of major depressive disorder, «DISEASE MARKERS», 2013, 35, pp. 33 - 41 [articolo]
Filippo Andreetta; Nicholas M. Barnes; Paul B. Wren; Lucia Carboni, p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms, «LIFE SCIENCES», 2013, 93, pp. 30 - 37 [articolo]
Gasperini L.; Piubelli C.; Carboni L., Proteomics of rat hypothalamus,hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP., «MOLECULAR BIOLOGY REPORTS», 2012, 39, pp. 2921 - 2935 [articolo]
Carboni L.; Negri M.; Michielin F.; Bertani S.; Delle Fratte S.; Oliosi B.; Cavanni P., Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release., «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2012, 15, pp. 645 - 656 [articolo]
Razzoli M.; Domenici E.; Carboni L.; Rantamaki T.; Lindholm J.;Castrén E.; Arban R., A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress., «GENES BRAIN AND BEHAVIOR», 2011, 10, pp. 424 - 433 [articolo]
Razzoli M.; Carboni L.; Andreoli M.; Ballottari A.; Arban R., Different susceptibility to social defeat stress of BalbC and C57BL6/J mice., «BEHAVIOURAL BRAIN RESEARCH», 2011, 216, pp. 100 - 108 [articolo]
Bison S.; Razzoli M.; Arban R.; Michielin F.; Bertani S.; Carboni L., Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats., «EUROPEAN JOURNAL OF PHARMACOLOGY», 2011, 661, pp. 49 - 56 [articolo]
Piubelli C.; Vighini M.; Mathé A.A.; Domenici E.; Carboni L., Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge., «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2011, 14, pp. 834 - 855 [articolo]
Piubelli C.; Vighini M.; Mathé A.A.; Domenici E.; Carboni L., Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background., «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2011, 14, pp. 796 - 833 [articolo]
Piubelli C.; Gruber S.; El Khoury A.; Mathé A.A.; Domenici E.; Carboni L., Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression., «EUROPEAN NEUROPSYCHOPHARMACOLOGY», 2011, 21, pp. 545 - 562 [articolo]
Carboni L.; Piubelli C.; Domenici E., Proteome effects of antidepressant medications., in: ‘Genomics, Proteomics, and the Nervous System’, NEW YORK, Springer, 2011, pp. 399 - 441 [capitolo di libro]
Piubelli C.; Carboni L.; Becchi S.; Mathé A.A.; Domenici E., Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis., «NEUROSCIENCE», 2011, 176, pp. 349 - 380 [articolo]
